APA (7th ed.) Citation

SP, S., B, T., J, L., LA, H., V, R., J, J., . . . FL, Y. (2024). Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology. Alzheimer's & dementia : the journal of the Alzheimer's Association, 20(12), 8855. https://doi.org/10.1002/alz.14346

Chicago Style (17th ed.) Citation

SP, Schauer, et al. "Pharmacodynamic Effects of Semorinemab on Plasma and CSF Biomarkers of Alzheimer's Disease Pathophysiology." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 20, no. 12 (2024): 8855. https://doi.org/10.1002/alz.14346.

MLA (9th ed.) Citation

SP, Schauer, et al. "Pharmacodynamic Effects of Semorinemab on Plasma and CSF Biomarkers of Alzheimer's Disease Pathophysiology." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 20, no. 12, 2024, p. 8855, https://doi.org/10.1002/alz.14346.